Salentra Biosciences is a biotechnology startup based out of St. Louis, Missouri. We are experts in the differentiation of human stem cell-derived islets. We are using our expertise to generate functionally mature SCIslets, at scale, for commercial distribution as research tools. We have developed strong partnerships with Dr. Jeffrey Millman’s lab and others to continue the development and commercialization of diabetes research tools.

​

​

​

Our mission is to use our proprietary state-of-the-art SCIslet differentiation technology to make stem cell-derived islets accessible to diabetes researchers.